Human prothrombin complex(Sichuan Yuanda Shuyang Pharmceutical)

人凝血酶原复合物（四川远大蜀阳药业）

Report date: 2025/12/22 15:36:17

Base Information

Drug NameHuman prothrombin complex(Sichuan Yuanda Shuyang Pharmceutical)
Drug Alias Name人凝血酶原复合物
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIICoagulation factor XCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhageHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesYuanda Shuyang Life Sciences (Chengdu) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYuanda Shuyang Life Sciences (Chengdu) Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia B
Inactive IndicationsHemorrhage

Other Information

ATC CodeN/A
Related LinksN/A